Quick Answer
Stem cell therapy for multiple sclerosis in India typically costs between $6,000 and $15,000 per treatment cycle, depending on the type of stem cells used, number of infusions, and hospital stay — roughly 70–85% less than equivalent treatment in the US or UK.
Cost Breakdown Table
| Treatment Type | Typical Cost Range (India) | What It Involves |
|---|---|---|
| Mesenchymal Stem Cell (MSC) therapy — IV/intrathecal | $4,000 – $10,000 | Autologous or allogeneic MSCs, 1–3 sessions, outpatient/short stay |
| Bone marrow–derived stem cell therapy | $6,000 – $12,000 | Cells harvested from patient’s own bone marrow, processed, re-infused |
| Autologous Hematopoietic Stem Cell Transplant (AHSCT) | $20,000 – $30,000 | Full immune-system “reset” — chemotherapy + stem cell transplant, hospital admission required |
Note: These are market-researched reference ranges compiled from multiple India-based clinics and medical tourism sources — not a quote. Replace with your clinic’s verified, current package pricing before publishing. Actual cost depends on the individual’s diagnosis, MS subtype, disease stage, and treatment protocol recommended after evaluation.
What Typically Affects the Final Cost
- Type of stem cells used (MSCs vs. hematopoietic vs. cord-derived) and their source (patient’s own body vs. donor)
- Number of infusion/injection sessions required
- Disease stage and MS subtype (relapsing-remitting vs. secondary progressive can call for different protocols)
- Length of hospital stay and pre/post-treatment diagnostic tests
- Additional therapies bundled in (physiotherapy, follow-up consultations)
- Accommodation and travel for international patients
India vs. Other Countries
| Country | Approx. Cost (USD) |
|---|---|
| India | $6,000 – $30,000 |
| United States | $20,000 – $100,000 |
| United Kingdom / Europe | $20,000 – $30,000+ |
India’s lower cost comes from lower medical and living expenses — not lower quality of care — which is why it has become a major destination for MS stem cell treatment-seekers globally.
What's Usually Included in a Package
- Initial neurologist/specialist consultation and MS evaluation
- Stem cell harvesting (if autologous) and lab processing
- The infusion/injection procedure itself
- Hospital stay (where applicable)
- Immediate post-treatment monitoring
Typically NOT included (state clearly to avoid disputes later): international flights, extended accommodation, visa costs, long-term follow-up beyond the initial period.
Is Stem Cell Therapy Right for You?
A short, honest section — who tends to be evaluated as a candidate (diagnosed MS patients seeking to manage progression/symptoms), and that suitability is determined only after a neurologist reviews MRI/diagnostic history. Avoid guaranteeing outcomes.
Important: Set Realistic Expectations
Be direct and honest here — this protects both the patient and the business from misleading-claims risk:
- There is currently no cure for multiple sclerosis; stem cell therapy is used to help manage symptoms and disease progression, not reverse existing nerve damage.
- Results vary by patient; large-scale clinical evidence is still developing (cite the PMC review on stem cell therapies in MS if you want an authoritative external citation).
- Only pursue treatment after a documented evaluation by a qualified neurologist.
Frequently Asked Questions
Stem cell therapy for multiple sclerosis in India typically costs between $6,000 and $15,000 per treatment cycle, depending on the type of stem cells used and the number of sessions — significantly less than the US or UK, where comparable treatment can run $20,000–$100,000.
No. It’s an emerging treatment aimed at managing symptoms and slowing progression; there’s currently no cure for MS.
The package typically covers your initial neurologist consultation, stem cell harvesting and lab processing, the infusion procedure, hospital stay where applicable, and immediate post-treatment monitoring. It usually does not include flights, extended accommodation, or long-term follow-up visits beyond the initial recovery period.
Lower medical infrastructure and staffing costs, not lower quality — India is a recognized medical tourism hub for regenerative therapies.
Suitability is determined after a neurologist reviews your diagnosis, MS subtype, and MRI history during an initial consultation.